Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Colonic Neoplasms × Resistance Training × Clear all

Phase

Status

Unknown 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Motor Activity 13 Neoplasms 10 Breast Neoplasms 10 Prostatic Neoplasms 6 Head and Neck Neoplasms 5 Obesity 4 Sarcopenia 3 Polycystic Ovary Syndrome 3 Lung Neoplasms 3 Uterine Cervical Neoplasms 2 Signs and Symptoms 2 Pharyngeal Neoplasms 2 Laryngeal Neoplasms 2 Fatigue 2 Diabetes Mellitus, Type 2 2 Colorectal Neoplasms 2 Weight Loss 1 Uterine Neoplasms 1 Urinary Incontinence 1 Sedentary Behavior 1 Sarcoma, Synovial 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rectal Neoplasms 1 Pituitary Neoplasms 1 Pelvic Floor Disorders 1 Pancreatic Neoplasms 1 Pancreatic Adenocarcinoma 1 Overweight 1

Interventions

Fluorouracil 116 Leucovorin 109 Oxaliplatin 93 Irinotecan 80 Bevacizumab 49 Cetuximab 37 Capecitabine 36 Folfox protocol 28 Panitumumab 20 Colonoscopy 16 Floxuridine 15 Chemotherapy, Adjuvant 15 Early Intervention, Educational 12 Erlotinib Hydrochloride 11 Surveys and Questionnaires 10 Immunohistochemistry 10 IFL protocol 10 Counseling 10 Psychiatric Rehabilitation 8 Methods 8 Gemcitabine 8 Exercise 8 Dexamethasone 8 Celecoxib 8 Gene Expression Profiling 7 Cyclophosphamide 7 Blood Specimen Collection 7 sargramostim 6 Radiotherapy 6 Polymerase Chain Reaction 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03291951 2022-07-28

FORCE

Kaiser Permanente

Phase NA Completed

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡